The firm said the decision was taken because of a decline in demand for the vaccine.
Countries including Australia have already ceased the supply of Vaxzevria, with its use discontinued since March 2023.
AstraZeneca had recently admitted in court documents that its vaccine against Covid-19 has the potential to cause TTS, a rare ...
AstraZeneca said it was "incredibly proud" of the vaccine, but it had made a commercial decision. It said the rise of new coronavirus variants meant demand had shifted to the newer updated vaccines.
, opens new tab said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic. The company also said it ...
Drugmaker AstraZeneca is reportedly pulling its COVID-19 vaccine from global markets due to a surplus of updated alternatives ...
The new development follows the company’s voluntary withdrawal of marketing authorisation for the vaccine in the European Union. Credit: rarrarorro / Shutterstock.com. AstraZeneca has begun the global ...
The company faced a class-action lawsuit that claimed the vaccine caused TTS – which stands for Thrombosis with ...
AstraZeneca has begun the worldwide withdrawal of its COVID vaccine - ending an era in which it saved millions of lives while being dogged by controversy. The jab, developed at Oxford University ...
We've made some important changes to our Privacy and Cookies Policy and we want you to know what this means for you and your data. We and our partners use ...
The Oxford-AstraZeneca Covid vaccine is being withdrawn worldwide, months after the pharmaceutical giant admitted for the first time in court documents that it can cause a rare and dangerous side ...
AstraZeneca's Covid-19 vaccine is associated with another rare but fatal blood clotting disorder, according to new findings ...